Work

Abstract PL04-02: Targeting MEK in KRAS mutant lung cancer.

Year: 2013

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-13-pl04-02

Author: Pasi A. Jänne

Institution: Dana-Farber Cancer Institute

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2024340458

Cites:

Cited by:

Related to: 10